# WIA-MED-011: Smart Pill Standard 💊

**Ingestible Sensor Technology for Health Monitoring and Drug Delivery**

## Overview

The Smart Pill standard (WIA-MED-011) defines comprehensive requirements for ingestible electronic devices that monitor health parameters, track medication adherence, and deliver drugs with precision inside the gastrointestinal tract.

**Philosophy**: 홍익인간 (弘益人間) - Benefit All Humanity

## Contents

### 📄 Main Landing Page
- **[index.html](./index.html)** - Main standard page with dark theme

### 📚 Korean Ebook (Complete)
- **[ebook/ko/index.html](./ebook/ko/index.html)** - 한국어 전자책 목차
- **Chapter 1-8**: Full Korean content covering all topics (200+ lines each)
  - Chapter 1: 개요 및 소개
  - Chapter 2: 섭취 가능 센서 기술
  - Chapter 3: 약물 전달 시스템
  - Chapter 4: 위장 모니터링
  - Chapter 5: 무선 통신
  - Chapter 6: 생체적합성 소재
  - Chapter 7: 규제 및 승인
  - Chapter 8: 구현 및 미래

### 📚 English Ebook (Complete)
- **[ebook/en/index.html](./ebook/en/index.html)** - English ebook table of contents
- **Chapter 1-8**: Full English content covering all topics
  - Chapter 1: Overview and Introduction
  - Chapter 2: Ingestible Sensor Technology
  - Chapter 3: Drug Delivery Systems
  - Chapter 4: Gastrointestinal Monitoring
  - Chapter 5: Wireless Communication
  - Chapter 6: Biocompatible Materials
  - Chapter 7: Regulation and Approval
  - Chapter 8: Implementation and Future

### 📋 Specifications
- **[spec/WIA-MED-011-v1.0.md](./spec/WIA-MED-011-v1.0.md)** - Technical specification

## Key Topics Covered

### Technology
- ✅ **Ingestible Sensors**: pH, temperature, pressure, biochemical, imaging
- ✅ **Drug Delivery Systems**: Controlled release, targeted delivery, multi-drug
- ✅ **Wireless Communication**: MICS, ISM bands, BLE, security protocols
- ✅ **Power Systems**: Batteries, energy harvesting (gastric acid)
- ✅ **AI & Edge Processing**: Onboard ML, real-time analysis

### Medical Applications
- ✅ **GI Monitoring**: pH profiling, motility assessment, transit time
- ✅ **Medication Tracking**: Adherence monitoring, pharmacokinetics
- ✅ **Disease Diagnosis**: GERD, IBD, gastroparesis, constipation
- ✅ **Therapeutic Delivery**: Site-specific, time-controlled, responsive

### Materials & Safety
- ✅ **Biocompatible Materials**: Gelatin, HPMC, enteric polymers, biodegradable
- ✅ **Sensor Coatings**: Nafion, polyurethane, anti-fouling
- ✅ **Safety Testing**: ISO 10993, USP Class VI, GI-specific
- ✅ **Degradation**: Intact excretion, biodegradation pathways

### Regulatory
- ✅ **FDA Approval**: 510(k), De Novo, PMA pathways
- ✅ **Clinical Trials**: IDE, GCP, endpoint design, statistics
- ✅ **International**: EU MDR, Japan PMDA, China NMPA
- ✅ **Post-Market**: Vigilance, registries, quality management (ISO 13485)

### Future
- ✅ **Emerging Tech**: Molecular sensors, OCT imaging, navigation
- ✅ **Interventional**: Biopsy, drug release, hemostasis
- ✅ **Long-term Vision**: Nanorobots, predictive medicine, symbiotic devices

## Technical Specifications

### Size
- Maximum: 15 mm diameter (ileocecal valve constraint)
- Typical: 8-12 mm
- Pediatric: 6-8 mm

### Sensors
| Type | Range | Accuracy | Response |
|------|-------|----------|----------|
| pH | 1.0-9.0 | ±0.1 | <30s |
| Temperature | 30-45°C | ±0.05°C | <10s |
| Pressure | 0-400 mmHg | ±1 mmHg | Real-time |
| Glucose | 0-500 mg/dL | ±10 mg/dL | <60s |

### Communication
- **MICS**: 402-405 MHz, EIRP ≤ 25 μW
- **ISM**: 2.4 GHz, 250 kbps - 2 Mbps
- **Security**: AES-256, HMAC-SHA256
- **Range**: 1-3 meters through tissue

### Power
- Operating: 1.5-3.0 V
- Average consumption: < 5 mW
- Battery life: 8-72 hours
- Energy harvesting: 10-100 μW (gastric acid)

## Safety

- **Biocompatibility**: ISO 10993, USP Class VI compliant
- **Obstruction risk**: < 0.01% (patency capsule screening)
- **Perforation risk**: < 0.001% (rounded design)
- **Battery**: Double-sealed, non-reactive materials
- **MRI**: Clearly labeled compatibility

## Clinical Workflow

1. **Screening** → Indications/contraindications check
2. **Consent** → Informed consent (risks/benefits)
3. **Preparation** → Diet, medications, education
4. **Ingestion** → Clinic or home, receiver activation
5. **Monitoring** → 8-72 hours, normal activities
6. **Analysis** → Automated + physician review
7. **Follow-up** → Results, treatment plan

## Standards Integration

This standard integrates with:
- **WIA-MED-001**: Medical data standards
- **WIA-MED-005**: Remote health monitoring
- **WIA-HEALTH**: Personal health records
- **WIA-IOT**: Internet of Things connectivity

## Quick Start

### View Ebooks
```bash
# Korean
open /home/user/wia-standards/smart-pill/ebook/ko/index.html

# English
open /home/user/wia-standards/smart-pill/ebook/en/index.html
```

### Read Specification
```bash
# Technical spec
cat /home/user/wia-standards/smart-pill/spec/WIA-MED-011-v1.0.md
```

## Contributing

This standard is part of the WIA Standards initiative. To contribute:
1. Review the specification and ebooks
2. Submit issues or suggestions
3. Propose enhancements via pull requests

## License

MIT License - Open for implementation and innovation

## Philosophy

**홍익인간 (弘益人間) - Benefit All Humanity**

Smart pill technology embodies this principle by:
- Enabling non-invasive health monitoring
- Improving medication adherence
- Advancing precision medicine
- Expanding healthcare access globally
- Reducing patient suffering and healthcare costs

---

**Version**: 1.0.0
**Date**: 2025-01-15
**Status**: ✅ Complete (All files created)

© 2025 WIA - World Certification Industry Association
